CCN1 and gastric adenocarcinoma: High expression of CCN1 was associated with shorter overall survival (OS) in five types of cancer [ACC, BLCA, brain lower grade glioma (LGG), mesothelioma (MESO), and stomach adenocarcinoma (STAD)] and longer OS only in SKCM, suggesting its role as a tumor suppressor.